🇺🇸 FDA
Patent

US 8431556

C-21-keto lupane derivatives preparation and use thereof

granted A61PA61P31/18

Quick answer

US patent 8431556 (C-21-keto lupane derivatives preparation and use thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P31/18